GlassScriptPhysician profile
Lisa A Posey
NPI 1225105927
$677.57
in general payments reported to CMS, 2019-2025
17 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.41 · 2020: $67.25 · 2021: $107 · 2022: $28.34 · 2023: $71.35 · 2024: $67.64 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $113.99 | 2023-2025 | Immunocap |
| Regeneron Healthcare Solutions, INC. | $112.07 | 2019-2025 | Dupixent |
| Intersect Ent, INC. | $67.25 | 2020 | |
| Preceptis Medical, INC. | $61.48 | 2021 | |
| Medtronic, INC. | $43.78 | 2023-2025 | Propel |
| Aerin Medical INC. | $36.48 | 2019-2022 | |
| Optinose US, INC. | $35.54 | 2019-2022 | |
| Stryker Corporation | $33.63 | 2021 | |
| Hologic Sales and Service, LLC | $29.47 | 2025 | Coolseal Generator |
| Davol INC. | $24.69 | 2025 | Arista |
| Integra Lifesciences Corporation | $21.15 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Astrazeneca Pharmaceuticals LP | $19.59 | 2025 | Tezspire |
| Amgen INC. | $18.24 | 2025 | Tezspire |
| Glaxosmithkline, LLC. | $18.10 | 2025 | Nucala |
| Phathom Pharmaceuticals, INC. | $17.26 | 2024 | Voquezna |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $14.06 | 2025 | |
| Covidien LP | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Posey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.